CNBX Pharmaceuticals Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Public

  • Employees
  • 2

Employees

  • Stock Symbol
  • CNBX

Stock Symbol

  • Investments
  • 3

CNBX Pharmaceuticals General Information

Description

CNBX Pharmaceuticals Inc is a clinical-stage biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing HTS technology and personalized bioinformatics tools. The company's main focus is the development of cannabinoid therapies and other technologies for the treatment of cancer, mainly cancers of the gastrointestinal tract, skin, breast, and prostate. The firm's main product is the Cannabics SR, an oral capsule developed for the treatment of patients with cancer and cancer anorexia cachexia syndrome (CACS). It also has an anti-neoplastic drug candidate under development for Colorectal Cancer (CRC) named RCC-33.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 3 Bethesda Metro Center
  • Suite 700
  • Bethesda, MD 20814
  • United States
+1 (877)
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
OTCM
Corporate Office
  • 3 Bethesda Metro Center
  • Suite 700
  • Bethesda, MD 20814
  • United States
+1 (877)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CNBX Pharmaceuticals Stock Performance

As of 20-Nov-2026, CNBX Pharmaceuticals’s current market cap is $241K with 1.61B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$241K 1.61B 7.88M

CNBX Pharmaceuticals Financials Summary

As of 31-May-2026, CNBX Pharmaceuticals has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 31-May-2026 FY 2025 31-Aug-2025 FY 2024 31-Aug-2024 FY 2023 31-Aug-2023
EV 1,398 1,373 1,413 1,576
Revenue 0 0 130 410
EBITDA (432) (274) (603) (3,547)
Net Income (462) (314) (695) (3,710)
Total Assets 13 18 31 499
Total Debt 1,167 1,197 1,295 1,344
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CNBX Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CNBX Pharmaceuticals‘s full profile, request access.

Request a free trial

CNBX Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
CNBX Pharmaceuticals Inc is a clinical-stage biotechnology company. It develops pharmaceuticals focusing on cancer resea
Biotechnology
Bethesda, MD
2 As of 2024

Las Vegas, NV
 

Basel, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CNBX Pharmaceuticals Competitors (15)

One of CNBX Pharmaceuticals’s 15 competitors is PharmaCyte Biotech, a Corporation company based in Las Vegas, NV.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PharmaCyte Biotech Corporation Las Vegas, NV
Roche Corporation Basel, Switzerland
Exact Sciences Formerly VC-backed Madison, WI
Avenir Wellness Solutions Formerly VC-backed Oxnard, CA
Skye Bioscience Formerly VC-backed San Diego, CA
You’re viewing 5 of 15 competitors. Get the full list »

CNBX Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CNBX Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CNBX Pharmaceuticals‘s full profile, request access.

Request a free trial

CNBX Pharmaceuticals Investments & Acquisitions (3)

CNBX Pharmaceuticals’s most recent deal was a Merger/Acquisition with TaGeza Biopharmaceuticals. The deal was made on 08-Nov-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
TaGeza Biopharmaceuticals 08-Nov-2022 Merger/Acquisition Drug Discovery
Wize Pharma/Cannabics Pharmaceuticals JV 07-Feb-2019 Joint Venture Other Pharmaceuticals and Biotechnology
Sativus Tech 17-Sep-2018 Secondary Transaction - Private Electrical Equipment
To view CNBX Pharmaceuticals’s complete investments and acquisitions history, request access »

CNBX Pharmaceuticals ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view CNBX Pharmaceuticals’s complete esg history, request access »

CNBX Pharmaceuticals Exits (1)

CNBX Pharmaceuticals’s most recent exit was on 17-Sep-2018 from Sativus Tech. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Sativus Tech 17-Sep-2018 Completed
To view CNBX Pharmaceuticals’s complete exits history, request access »

CNBX Pharmaceuticals FAQs

  • When was CNBX Pharmaceuticals founded?

    CNBX Pharmaceuticals was founded in 2004.

  • Where is CNBX Pharmaceuticals headquartered?

    CNBX Pharmaceuticals is headquartered in Bethesda, MD.

  • What is the size of CNBX Pharmaceuticals?

    CNBX Pharmaceuticals has 2 total employees.

  • What industry is CNBX Pharmaceuticals in?

    CNBX Pharmaceuticals’s primary industry is Biotechnology.

  • Is CNBX Pharmaceuticals a private or public company?

    CNBX Pharmaceuticals is a Public company.

  • What is CNBX Pharmaceuticals’s stock symbol?

    The ticker symbol for CNBX Pharmaceuticals is CNBX.

  • What is the current market cap of CNBX Pharmaceuticals?

    The current market capitalization of CNBX Pharmaceuticals is $241K.

  • Who are CNBX Pharmaceuticals’s competitors?

    PharmaCyte Biotech, Roche, Exact Sciences, Avenir Wellness Solutions, and Skye Bioscience are some of the 15 competitors of CNBX Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process